Quantitative Systematic Strategies LLC Akero Therapeutics, Inc. Transaction History

Quantitative Systematic Strategies LLC

  • $0
  • Q3 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 06, 2021
BUY
$24.04 - $34.19 $2,019 - $2,871
84 Added 0.72%
11,728 $340,000
Q4 2020

Feb 09, 2021
BUY
$25.12 - $29.89 $37,931 - $45,133
1,510 Added 14.9%
11,644 $300,000
Q3 2020

Nov 09, 2020
BUY
$30.79 - $39.92 $312,025 - $404,549
10,134 New
10,134 $312,000

Others Institutions Holding AKRO

# of Institutions
210
Shares Held
74.3M
Call Options Held
321K
Put Options Held
558K
View Full List

About Akero Therapeutics, Inc.

AKRO Quotes by TradingView
  • Ticker AKRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,417,600
  • Market Cap $2.08B
  • Description
  • Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...
More about AKRO
Track This Portfolio

Track Quantitative Systematic Strategies LLC Portfolio

Follow Quantitative Systematic Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email